Abstract
Early contraceptive advice is essential in women with heart disease and should be considered as an integral part of standard treatment in these women. When considering a contraceptive method, the efficacy, inherent risks and benefits are evaluated in relation to the particularities of the cardiac condition. For this, potential interactions with cardiovascular drugs, effects on coagulation and haemodynamics are of particular importance. By appropriate counselling, including the woman’s preference, personalised advice is given by a multidisciplinary team. In this chapter, we consider the different methods of contraception in relation to the type of heart disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- COC:
-
Combined oral contraceptives
- DMPA:
-
Depot-medroxyprogesterone acetate
- IUDs:
-
Intrauterine devices
- LARC:
-
Long-acting reversible contraceptives
- LNG-IUS:
-
Levonorgestrel-releasing intrauterine system
- PCOS:
-
Polycystic ovary syndrome
- PID:
-
Pelvic inflammatory disease
- WHO-MEC:
-
WHO medical eligibility criteria
References
Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31(23):2915–2957
Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U, Webb GD, Niwa K et al (2013) Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 34(9):657–665
Kaunitz AM (1999) Oral contraceptive health benefits: perception versus reality. Contraception 59(1 Suppl):29s–33s
Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95(2):261–266
Dragoman MV (2014) The combined oral contraceptive pill – recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol 28(6):825–834
Wellings K, Brima N, Sadler K, Copas AJ, McDaid L, Mercer CH et al (2015) Stopping and switching contraceptive methods: findings from Contessa, a prospective longitudinal study of women of reproductive age in England. Contraception 91(1):57–66
Rogers P, Mansour D, Mattinson A, O’Sullivan JJ (2007) A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care R Coll Obstet Gynaecol 33(1):17–21
Pijuan-Domenech A, Baro-Marine F, Rojas-Torrijos M, Dos-Subira L, Pedrosa-Del Moral V, Subirana-Domenech MT et al (2013) Usefulness of progesterone-only components for contraception in patients with congenital heart disease. Am J Cardiol 112(4):590–593
Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N et al (2006) Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care, R Coll Obstet Gynaecol 32(2):75–81
Trussell J (2011) Contraceptive failure in the United States. Contraception 83(5):397–404
Mansour D, Bahamondes L, Critchley H, Darney P, Fraser IS (2011) The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users. Contraception 83(3):202–210
Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS (2008) The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care Off J Eur Soc Contracept 13(Suppl 1):13–28
Modesto W, Bahamondes MV, Bahamondes L (2014) A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod 29(7):1393–1399
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197
WHO Guidelines Approved by the Guidelines Review Committee. Medical eligibility criteria for contraceptive use (2015) World Health Organization, Geneva. Copyright (c) World Health Organization 2015
Mohan AR, Nelson-Piercy C (2014) Drugs and therapeutics, including contraception, for women with heart disease. Best Pract Res Clin Obstet Gynaecol 28(4):471–482
Milsom I, Korver T (2008) Ovulation incidence with oral contraceptives: a literature review. J Family Plan Reprod Health Care Fac Family Plan Reprod Health Care R Coll Obstet Gynaecol 34(4):237–246
Anderson FD (2006) Safety and efficacy of an extended-regimen oral contraception utilizing low-dose ethinyl estradiol. Contraception 74(4):355
Dong W, Colhoun HM, Poulter NR (1997) Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994. J Hypertens 15(10):1063–1068
Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366(24):2257–2266
Silversides CK, Sermer M, Siu SC (2009) Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 11(4):298–305
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747
Ellison J, Thomson AJ, Greer IA, Walker ID (2000) Drug points: apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ (Clin Res Ed) 321(7273):1382
Thorne S, MacGregor A, Nelson-Piercy C (2006) Risks of contraception and pregnancy in heart disease. Heart 92(10):1520–1525
Korver T, Klipping C, Heger-Mahn D, Duijkers I, van Osta G, Dieben T (2005) Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake. Contraception 71(1):8–13
Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI (2012) Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ (Clin Res Ed) 345:e4944
Wald RM, Sermer M, Colman JM (2011) Pregnancy and contraception in young women with congenital heart disease: general considerations. Paediatr Child Health 16(4):e25–e29
Espey E, Ogburn T (2011) Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol 117(3):705–719
Stephen Searle E (2014) The intrauterine device and the intrauterine system. Best Pract Res Clin Obstet Gynaecol 28(6):807–824
Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I (2011) Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 84(5):e11–e16
Kapp N, Curtis KM (2009) Intrauterine device insertion during the postpartum period: a systematic review. Contraception 80(4):327–336
Vigl M, Kaemmerer M, Niggemeyer E, Nagdyman N, Seifert-Klauss V, Trigas V et al (2010) Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol 105(4):538–541
Huq FY, Tvarkova K, Arafa A, Kadir RA (2011) Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation. Contraception 84(2):128–132
Zingone MM, Guirguis AB, Airee A, Cobb D (2009) Probable drug interaction between warfarin and hormonal contraceptives. Ann Pharmacother 43(12):2096–2102
Murray S, Hickey JB, Houang E (1987) Significant bacteremia associated with replacement of intrauterine contraceptive device. Am J Obstet Gynecol 156(3):698–700
Everett ED, Reller LB, Droegemueller W, Greer BE (1976) Absence of bacteremia after insertion or removal of intrauterine devices. Obstet Gynecol 47(2):207–209
Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT et al (2008) ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52(8):676–685
Centre for Clinical Practice at N. National Institute for Health and Clinical Excellence: Guidance Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (2008) National Institute for Health and Clinical Excellence (UK) National Institute for Health and Clinical Excellence, London
Grimes DA, Schulz KF (2001) Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev (2):Cd001327
Ladipo OA, Farr G, Otolorin E, Konje JC, Sturgen K, Cox P et al (1991) Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion. Adv Contracept Off J Soc Adv Contracept 7(1):43–54
Sinei SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM et al (1990) Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 97(5):412–419
Walsh TL, Bernstein GS, Grimes DA, Frezieres R, Bernstein L, Coulson AH (1994) Effect of prophylactic antibiotics on morbidity associated with IUD insertion: results of a pilot randomized controlled trial, IUD Study Group. Contraception 50(4):319–327
Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH (2015) Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet (Lond, Engl) 385(9974):1219–1228
Suri V, Aggarwal N, Kaur R, Chaudhary N, Ray P, Grover A (2008) Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease. Contraception 78(4):315–318
Gemzell-Danielsson K, Mansour D, Fiala C, Kaunitz AM, Bahamondes L (2013) Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 19(4):419–427
Ott J, Promberger R, Kaufmann U, Huber JC, Frigo P (2009) Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation. Arch Gynecol Obstet 280(5):811–814
Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG, Veldtman GR, Johnson MR (2015) Contraception and cardiovascular disease. Eur Heart J 36(27):1728–1734, 34a-34b
Jacobstein R, Polis CB (2014) Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynaecol 28(6):795–806
Aznar R, Reynoso L, Ley E, Gamez R, De Leon MD (1976) Electrocardiographic changes induced by insertion of an intrauterine device and other uterine manipulations. Fertil Steril 27(1):92–96
Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E (2011) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–9. BMJ (Clin Res Ed) 343:d6423
Culwell KR, Curtis KM (2009) Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. Contraception 80(4):337–345
Kadir RA, Chi C (2007) Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy. Contraception 75(6 Suppl):S123–S129
Pisoni CN, Cuadrado MJ, Khamashta MA, Hunt BJ (2006) Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus 15(12):877–880
Sordal T, Inki P, Draeby J, O’Flynn M, Schmelter T (2013) Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial. Obstet Gynecol 121(5):934–941
Lidegaard O, Nielsen LH, Skovlund CW, Lokkegaard E (2012) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–10. BMJ (Clin Res Ed) 344:e2990
Goldstein J, Cushman M, Badger GJ, Johnson JV (2007) Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 87(6):1267–1270
Snabes MC, Poindexter AN 3rd (1991) Laparoscopic tubal sterilization under local anesthesia in women with cyanotic heart disease. Obstet Gynecol 78(3 Pt 1):437–440
Hillis SD, Marchbanks PA, Tylor LR, Peterson HB (1999) Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 93(6):889–895
Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J (1996) The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 174(4):1161–1168; discussion 8–70
Adelman MR, Dassel MW, Sharp HT (2014) Management of complications encountered with Essure hysteroscopic sterilization: a systematic review. J Minim Invasive Gynecol 21(5):733–743
Famuyide AO, Hopkins MR, El-Nashar SA, Creedon DJ, Vasdev GM, Driscoll DJ et al (2008) Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc 83(4):431–438
Duffy S, Marsh F, Rogerson L, Hudson H, Cooper K, Jack S et al (2005) Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 112(11):1522–1528
Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D et al (2003) Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study. Hum Reprod 18(6):1223–1230
Dhruva SS, Ross JS, Gariepy AM (2015) Revisiting essure – toward safe and effective sterilization. N Engl J Med 373(15), e17
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Erkamp, J.S., Cornette, J. (2017). Contraception and Cardiovascular Disease. In: Roos-Hesselink, J., Johnson, M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-38913-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-38911-0
Online ISBN: 978-3-319-38913-4
eBook Packages: MedicineMedicine (R0)